Observational study of heart failure patients in Vietnam
Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study
This study is looking to gather information about heart failure patients in Vietnam to see how they are doing after leaving the hospital and how different treatments affect their health over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Medical Center Ho Chi Minh City (UMC) Academic / other |
| Locations | 1 site (Ho Chi Minh City) |
| Trial ID | NCT06516562 on ClinicalTrials.gov |
What this trial studies
This study aims to collect and analyze demographic, clinical, biological, and treatment characteristics of patients diagnosed with heart failure in Vietnam. It will follow patients discharged with heart failure with reduced or mildly reduced ejection fraction, gathering data at the time of discharge and at 1, 3, and 12 months post-discharge. The study will utilize standardized data definitions to ensure consistency and accuracy in data collection, focusing on various clinical outcomes and treatment responses. The information will be gathered through direct communication with patients and recorded using the REDCap system.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been diagnosed with heart failure and have a left ventricular ejection fraction of less than 50%.
Not a fit: Patients who lack communication means with healthcare staff or do not reside in Vietnam after discharge will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of heart failure management and improve patient outcomes in Vietnam.
How similar studies have performed: Other observational studies in heart failure have shown success in identifying treatment patterns and outcomes, suggesting this approach is valid and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years and older * Diagnosed with heart failure at the time of discharge * Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50% Exclusion Criteria: * Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.) * Patients do not reside in Vietnam after discharge
Where this trial is running
Ho Chi Minh City
- University Medical Center Ho Chi Minh City — Ho Chi Minh City, Vietnam (Recruiting)
Study contacts
- Principal investigator: Hoang Vu Vu, PhD — University of Medicine and Pharmacy at Ho Chi Minh City
- Study coordinator: Hoang Vu Vu, MD, PhD
- Email: vu.vh@umc.edu.vn
- Phone: +84908431304
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.